Shareholders meeting

August 6, 2026 To, To, Dy. General Manager The Manager - Listing, Department of Corporate Services, National Stock Exchange of India Ltd., BSE Ltd., Plot No. C/1, G Block, P. J. Towers, Dalal Street, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Ref: Scrip Code: 543322 Ref: Scrip Name: ALIVUS Dear Sirs, Subject: Intimation of 15th Annual General Meeting and Record Date ThisistoinformyouthattheFifteenth(15th)AnnualGeneralMeeting(‘AGM’)oftheCompanywill be held on Tuesday, September 8, 2026, at 03:00 pm (IST) through Video Conferencing (‘VC’) or OtherAudio-VisualMeans(‘OAVM’),inaccordance,withtherelevantcircularsissuedbyMinistryof Corporate Affairs and Securities and Exchange Board of India (‘SEBI’). Asinformedearlier,theBoardofDirectorsatitsmeetingheldonMay14,2026,hadrecommended afinaldividendofRs.5.00perEquityshareofRs.2eachoftheCompanyforthefinancialyearended March 31, 2026, for approval by the shareholders at the AGM. Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Company has fixed Tuesday, September 1, 2026, as the ‘Record Date’ for the purpose of determining the entitlement of Members to receive the aforesaid dividend for the financial year ended March 31, 2026. If the aforesaid dividend as recommended by the Board of Directors is approved at the AGM, payment of such dividend, subject to deduction of tax at source, will be made on or after Friday, September 11, 2026 as under: a) To all Beneficial Owners in respect of shares held in dematerialized form as per the data as may be made available by the National Securities Depository Limited and the Central DepositoryServices(India)LimitedasofthecloseofbusinesshoursonTuesday,September 1, 2026. b) To all Members in respect of shares held in physical form after giving effect to valid transmissionortranspositionrequestslodgedwiththeCompanyasofthecloseofbusiness hours on Tuesday, September 1, 2026. Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) Corporate Office: Registered Office: Technopolis Knowledge Park, A wing, Office No. 401 to 407, Plot No 170-172, Chandramouli Industrial Estate 4th Floor, Mahakali Caves Road, Andheri (E), Mumbai – 400093 Mohol Bazarpeth, Solapur 413 213, India T: +91 22 6829 7979 | CIN: L74900PN2011PLC139963 | E: complianceofficer@alivus.com | W: www.alivus.com This will also be posted on the Company’s website at www.alivus.com This is for your information and records. Thanking you Yours faithfully, For Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) Rudalf Corriea Company Secretary & Compliance Officer